{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T18:45:48Z","timestamp":1770576348753,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,29]],"date-time":"2015-10-29T00:00:00Z","timestamp":1446076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,10,29]],"date-time":"2015-10-29T00:00:00Z","timestamp":1446076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Impot Res"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1038\/ijir.2015.27","type":"journal-article","created":{"date-parts":[[2015,10,29]],"date-time":"2015-10-29T09:16:29Z","timestamp":1446110189000},"page":"20-24","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Relaxant effect of a metal-based drug in human corpora cavernosa and its mechanism of action"],"prefix":"10.1038","volume":"28","author":[{"given":"A S","family":"Leit\u00e3o Junior","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R M","family":"Campos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J B G","family":"Cerqueira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M C","family":"Fonteles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C F","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"de Nucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E H S","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L G F","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L F","family":"Gonzaga-Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N R F","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,29]]},"reference":[{"key":"BFijir201527_CR1","doi-asserted-by":"crossref","unstructured":"NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA 1993; 7: 83\u201390.","DOI":"10.1001\/jama.270.1.83"},{"key":"BFijir201527_CR2","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/S0022-5347(05)67900-1","volume":"163","author":"CB Johannes","year":"2000","unstructured":"Johannes CB, Ara\u00fajo AB, Feldman HA . Incidence of erectile dysfunction in men ages 40-69: longitudinal results from the Massachusetts male aging study. J Urol 2000; 163: 460\u2013469.","journal-title":"J Urol"},{"key":"BFijir201527_CR3","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0090-4295(01)01274-2","volume":"58","author":"ED Moreira Jr","year":"2001","unstructured":"Moreira ED Jr, Abdo CH, Torres EB, Lobo CF, Fittipaldi JA . Prevalence and correlates of erectile dysfunction: results of the Brazilian study of sexual behavior. Urology 2001; 58: 583\u2013588.","journal-title":"Urology"},{"key":"BFijir201527_CR4","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S0165-6147(00)01587-X","volume":"21","author":"TJ Bivalacqua","year":"2000","unstructured":"Bivalacqua TJ, Champion HC, Hellstrom WJ, Kadowitz PJ . Pharmacotherapy for erectile dysfunction. Trends Pharmacol Sci 2000; 21: 484\u2013489.","journal-title":"Trends Pharmacol Sci"},{"key":"BFijir201527_CR5","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/288373a0","volume":"288","author":"RF Furchgott","year":"1980","unstructured":"Furchgott RF, Zawadzki JV . The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373\u2013376.","journal-title":"Nature"},{"key":"BFijir201527_CR6","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/327524a0","volume":"327","author":"RM Palmer","year":"1987","unstructured":"Palmer RM, Ferrige AG, Moncada S . Nitric oxide accounts for the biological activity of endothelium derived relaxing factor. Nature 1987; 327: 524\u2013526.","journal-title":"Nature"},{"key":"BFijir201527_CR7","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/0006-291X(90)92168-Y","volume":"31","author":"LJ Ignarro","year":"1990","unstructured":"Ignarro LJ, Bush PA, Buga GM, Wood KS, Fukuto JM, Rajfer J . Nitric oxide andcyclic GMP formation upon electrical field stimulation cause relaxation of corpuscavernosum smooth muscle. Biochem Biophys Res Commun 1990; 31: 843\u2013850.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFijir201527_CR8","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1124\/pr.111.004515","volume":"63","author":"KE Andersson","year":"2011","unstructured":"Andersson KE . Mechanisms of penile erection and basis for pharmacological treatment of erectile dysfunction. Pharmacol Rev 2011; 63: 811\u2013859.","journal-title":"Pharmacol Rev"},{"issue":"Suppl 2","key":"BFijir201527_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/S0090-4295(02)01686-2","volume":"60","author":"JD Corbin","year":"2002","unstructured":"Corbin JD, Francis SH, Webb DJ . Phosphodiesterase type 5 as a pharmacologic target in erectile dysfunction. Urology 2002; 60 (Suppl 2): 4\u201311.","journal-title":"Urology"},{"key":"BFijir201527_CR10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.vph.2006.10.002","volume":"46","author":"D Bonaventura","year":"2007","unstructured":"Bonaventura D, de Lima RG, Vercesi JA, da Silva RS, Bendhack LM . Comparison of the mechanisms underlying the relaxation induced by two nitric oxide donors: Sodium nitroprusside and a new ruthenium complex. Vascul Pharmacol 2007; 46: 215\u2013222.","journal-title":"Vascul Pharmacol"},{"key":"BFijir201527_CR11","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S0302-2838(02)00397-4","volume":"42","author":"M Seidler","year":"2002","unstructured":"Seidler M, \u00dcckert S, Waldkirch E, Stief CG, Oelke M, Tsikas D et al. In vitro effects of a novel class of nitric oxide (NO) donating compounds on isolated human erectile tissue. Eur Urol 2002; 42: 523\u2013528.","journal-title":"Eur Urol"},{"key":"BFijir201527_CR12","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.niox.2011.11.005","volume":"26","author":"E Tfouni","year":"2012","unstructured":"Tfouni E, Truzzi DR, Tavares A, Gomes AJ, Figueiredo LE, Franco DW . Biological activity of ruthenium nitrosyl complexes. Nitric Oxide 2012; 26: 38\u201353.","journal-title":"Nitric Oxide"},{"key":"BFijir201527_CR13","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1002\/ejic.200500871","volume":"2006","author":"FON Silva","year":"2006","unstructured":"Silva FON, Ara\u00fajo SXB, Holanda AKM, Meyer E, Sales FAM, Di\u00f3genes ICN et al. Synthesis, characterization, and NO release study of the cis- and trans-[Ru(Bpy)2(SO3)(NO)]+ complexes. Eur J Inorg Chem 2006; 2006: 2020\u20132026.","journal-title":"Eur J Inorg Chem"},{"key":"BFijir201527_CR14","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1590\/S0100-879X2009000100013","volume":"42","author":"CN Lunardi","year":"2009","unstructured":"Lunardi CN, da Silva RS, Bendhack LM . New nitric oxide donors based on ruthenium complexes. Braz J Med Biol Res 2009; 42: 87\u201393.","journal-title":"Braz J Med Biol Res"},{"key":"BFijir201527_CR15","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1590\/S1677-55382008000500013","volume":"34","author":"JB Cerqueira","year":"2008","unstructured":"Cerqueira JB, Gonzaga-Silva LF, Lopes LG, Moraes ME, Nascimento NR . Relaxation of rabbit corpus cavernosum smooth muscle and aortic vascular endothelium induced by new nitric oxide donor substances of the nitrosyl-ruthenium complex. Int Braz J Urol 2008; 34: 638\u2013645.","journal-title":"Int Braz J Urol"},{"key":"BFijir201527_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ejphar.2003.08.012","volume":"477","author":"JS Baracat","year":"2003","unstructured":"Baracat JS, Teixeira CE, Okuyama CE, Priviero FB, Faro R, Antunes E et al. Relaxing effects induced by the soluble guanylylcyclasestimulator BAY41-2272 in human and rabbit corpus cavernosum. Eur J Pharmacol 2003; 477: 163\u2013169.","journal-title":"Eur J Pharmacol"},{"key":"BFijir201527_CR17","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/S0090-4295(02)02121-0","volume":"61","author":"E Bischoff","year":"2003","unstructured":"Bischoff E, Schramm M, Straub A, Feurer A, Stasch JP . BAY 41\u20132272: a stimulator of soluble guanylylcyclase induces nitric oxide-dependent penile erection in vivo. Urology 2003; 61: 464\u2013467.","journal-title":"Urology"},{"key":"BFijir201527_CR18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2174\/1570161052773933","volume":"3","author":"JC Wanstall","year":"2005","unstructured":"Wanstall JC, Homer KL, Doggrell SA . Evidence for, and importance of, cGMP-independent mechanisms with NO and NO donors on blood vessels and platelets. Curr Vasc Pharmacol 2005; 3: 41\u201353.","journal-title":"Curr Vasc Pharmacol"},{"key":"BFijir201527_CR19","doi-asserted-by":"publisher","first-page":"10848","DOI":"10.1021\/bi9929296","volume":"39","author":"Y Zhao","year":"2000","unstructured":"Zhao Y, Brandish PE, Divalentim M, Schelvis JP, Babcok GT, Marletta MA . Inhibition of soluble guanylatecyclaseby ODQ. Biochemistry 2000; 39: 10848\u201310854.","journal-title":"Biochemistry"},{"key":"BFijir201527_CR20","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1124\/mol.56.2.243","volume":"56","author":"M Feelish","year":"1999","unstructured":"Feelish M, Kotsonis P, Siebe J . The soluble guanylylcyclase inhibitor 1-H-[1,2,4] oxadiazolo-[4,3-a] quinoxaline 1-one is a non selectivehaem protein inhibitor of nitric oxide synthase and other cytochrome P450 enzymes involved in nitric oxide donor bioactivation. Mol Pharmacol 1999; 56: 243\u2013253.","journal-title":"Mol Pharmacol"},{"key":"BFijir201527_CR21","doi-asserted-by":"publisher","first-page":"H1153","DOI":"10.1152\/ajpheart.01101.2009","volume":"299","author":"AM Badejo Jr","year":"2010","unstructured":"Badejo AM Jr, Nossaman VE, Pankey EA, Bhartiya M, Kannadka CB, Murthy SN et al. Pulmonary and systemic vasodilator responses to the soluble guanylylcyclase stimulator, BAY 41-8543, are modulated by nitric oxide. Am J Physiol Heart Circ Physiol 2010; 299: H1153\u2013H1159.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFijir201527_CR22","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1161\/01.CIR.0000144469.01521.8A","volume":"110","author":"OV Evgenov","year":"2004","unstructured":"Evgenov OV, Ichinose F, Evgenov NV, Gnoth MJ, Falkowski GE, Chang Y et al. Soluble guanylatecyclase activator reverses acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitricoxide in awake lambs. Circulation 2004; 110: 2253\u20132259.","journal-title":"Circulation"},{"key":"BFijir201527_CR23","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S0165-6147(97)01137-1","volume":"18","author":"AJ Hobbs","year":"1997","unstructured":"Hobbs AJ . Soluble guanylatecyclase: the forgotten sibling. Trends Pharmacol Sci 1997; 18: 484\u2013491.","journal-title":"Trends Pharmacol Sci"},{"key":"BFijir201527_CR24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1046\/j.1365-2605.2003.00403.x","volume":"26","author":"S Filippi","year":"2003","unstructured":"Filippi S, Crescioli C, Vannelli GB, Fazzini A, Natali A, Riffaud JP et al. Effects of NCX 4050, a new NO donor, in rabbit and human corpus cavernosum. Int J Androl 2003; 26: 101\u2013108.","journal-title":"Int J Androl"},{"key":"BFijir201527_CR25","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/S0090-4295(96)00218-X","volume":"48","author":"CK H\u00f6ppner","year":"1996","unstructured":"H\u00f6ppner CK, Stief CG, Jonas U, Mandrek K, Noack T, Golenhofen K . Eletrical and chemical control of smooth muscle activity of rabbit corpus cavernosum in vitro. Urology 1996; 48: 512\u2013518.","journal-title":"Urology"},{"key":"BFijir201527_CR26","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1476-5381.1988.tb16553.x","volume":"95","author":"LM Videbaek","year":"1988","unstructured":"Videbaek LM, Aalkjaer C, Mulvany MJ . Pinacidil opens K-selective channels causing hyperpolarization andrelaxation of noradrenaline contractions in rat mesenteric resistance vessels. Br J Pharmacol 1988; 95: 103\u2013108.","journal-title":"Br J Pharmacol"},{"key":"BFijir201527_CR27","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/ijir.2009.41","volume":"21","author":"FC Freitas","year":"2009","unstructured":"Freitas FC, Nascimento NR, Cerqueira JB, Morais ME, Regadas RP, Gonzaga-Silva LF . Yohimbine relaxes the human corpus cavernosum through a non-adrenergic mechanism involving the activation of K+ATP-dependent channels. Int J Impot Res 2009; 21: 356\u2013361.","journal-title":"Int J Impot Res"},{"key":"BFijir201527_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/sj.ijir.3901269","volume":"17","author":"LF Gonzaga-Silva","year":"2005","unstructured":"Gonzaga-Silva LF, Nascimento NR, Fonteles MC, deNucci G, Moraes ME, Vasconcelos PR et al. Phentolamine relaxes human corpus cavernosumby a nonadrenergicmechanism activating ATP-sensitive K channel. Int J Impot Res 2005; 17: 27\u201332.","journal-title":"Int J Impot Res"},{"key":"BFijir201527_CR29","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1590\/S1677-55382012000500015","volume":"38","author":"JB Cerqueira","year":"2012","unstructured":"Cerqueira JB, Gonzaga-Silva LF, Silva FO, Cerqueira JV, Oliveira RR, Moraes ME et al. Identification of mechanisms involved in the relaxation of rabbit cavernous smooth muscle by a new nitric oxide donor ruthenium compound. Int Braz J Urol 2012; 38: 687\u2013694.","journal-title":"Int Braz J Urol"}],"container-title":["International Journal of Impotence Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ijir201527.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ijir201527","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ijir201527.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T16:43:32Z","timestamp":1648658612000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ijir201527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,29]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["BFijir201527"],"URL":"https:\/\/doi.org\/10.1038\/ijir.2015.27","relation":{},"ISSN":["0955-9930","1476-5489"],"issn-type":[{"value":"0955-9930","type":"print"},{"value":"1476-5489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,29]]},"assertion":[{"value":"14 January 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}